期刊文献+

迟发型先天性鸟氨酸氨甲酰基转移酶缺陷病临床及家系分析 被引量:1

Clinical and pedigree analysis of late onset congenital ornithine transcarbamylase deficiency in a child
原文传递
导出
摘要 目的总结分析1例先天性鸟氨酸氨甲酰基转移酶缺乏症(OTCD)患儿的临床特征及其家系特点,提高临床医师对该病的认识。方法对本院确诊的1例OTCD患儿临床特点进行分析。采取外周血利用直接测序技术对患儿及其父母、姐姐鸟氨酸氨甲酰基转移酶(OTC)基因的10个外显子及其相邻9个内含子进行基因分析。并对患儿二、三级亲属发病情况进行调查。结果患儿于出生后6个月起病,临床表现为反复发作性呕吐、精神差、血氨增高、肝功能异常。一同胞哥哥因同样表现于生后6个月夭折,一同胞姐姐健康。基因检测显示患儿携带IVS1—2A〉G内含子突变,患儿母亲及姐姐为携带者,父亲未发现基因突变。,患儿外祖父母、舅舅及其子女均健康。结论OTCD是一种先天遗传性疾病,也是高氨血症常见的原因之一,临床表现多样而易误诊。OTC基因IVS1—2A〉G突变是导致本例患儿发病的原因,本家系发病情况提示该患儿为x连锁隐性遗传疾病。 Objective To raise the awareness of congenital ornithine transcarbamylase deficiency (OTCD) by analyzing the clinical features and the family pedigree in a child with OTCD. Methods Clinical characteristics were analyzed in a child with OTCD. The genetic analysis was performed in ten exons and nine intron-exon boundaries in the ornithine transcarbamylase (OTC) gene of the case and his family by direct sequencing of PCR-DNA from peripheral blood. Family history including his grandparents and uncle was registered. Results The onset age of the case was 6 months old, the clinical picture was characterized by recurrent episodes of vomiting, low spirits, hyperammonemia, and abnormal liver function. His brother died of the similar performance at 6 months old. His sister was healthy. IVS1-2A〉G intron mutation of OTC gene was found in the case, while his mother and sister were the carriers and his father revealed no mutation. His maternal grandparents and his unele's family were healthy. Conclusion OTCD is a kimi of congenital genetic disease, and is one of the main causes of hyperammonemia. Misdiagnosis is very common because clinical symptoms of this disease are variable. [VS1-2A〉G mutation in OTC gene is the pathogeny of this case. The family genealogy indicates that this case is a kind of X-linked recessive hereditary disease.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第9期782-784,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 鸟氨酸氨甲酰基转移酶 尿素循环障碍 儿童 基因诊断 高氨血症 Omithine transearbamylase Urea cycle disorder Child Genetic diagnosis Hyperammonemia
  • 相关文献

参考文献6

二级参考文献55

  • 1宋元宗,张霆,张春花,王自能.尿素酶预处理-气相色谱-质谱法选择性筛查遗传代谢病高危患儿327例初步研究[J].实用儿科临床杂志,2005,20(2):142-144. 被引量:18
  • 2周平,宋元宗,肖昕,柳国胜.鸟氨酸氨甲酰基转移酶缺陷病1例[J].实用儿科临床杂志,2006,21(8):459-459. 被引量:10
  • 3Hori D,Hasegawa Y,Kimura M,et al. Clinical onset and prognosis of Asian children with organic acidemias, as detected by analysis of urinary acids using GC/MS, instead of mass screening. Brain Dev, 2005,27:39-45.
  • 4Gordon N.Omithine transcarbamylase deficiency:a urea cycle defect.Eur J Paediatr Neurol,2003,7:115-121.
  • 5Lee B,Goss J.Long-term correction of urea cycle disorders.J Pediatr,2001,138:S62-S71.
  • 6Maestri NE,Clissold D,Brusilow SW.Neonatal onset ornithine transcarbamylase deficiency:A retrospective analysis.J Pediatr,1999,134:268-272.
  • 7Mendez-Figueroa H,Lamance K,Sutton VR,et al.Managementof ornithine transcarbamylase deficiency in pregnancy.Am JPerinatol,2010,27:775-784.
  • 8Cordero DR,Baker J,Dorinzi D,et al.Ornithine transcarbamylase deficiency in pregnancy.J Inherit Metab Dis,2005,28:237-240.
  • 9Chace DH,Kalas TA,Naylor EW.The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism.Annu Rev Genomics Hum Genet,2002,3:17-45.
  • 10Ia Marca G,Casetta B,Zammarchi E.Rapid determination of orotic acid in urine by a fast liquid chromatography/tandem mass spectrometric method.Rapid Commun Mass Spectrom,2003,17:788-793.

共引文献44

同被引文献7

  • 1Serrano M, Perez-Duenas B, Gomez-Lopez L, et al.Neuropsychiatric manifestations in late-onset urea cycle disorder patients [J]. J Child Neurol, 2010 ,25 ( 3 ) : 352-358 .
  • 2Haber J. Clinical practice: the management of hyperammonemia[J]. Eur J pediar,2011,170 ( 1 ) :21-34.
  • 3Msall M, Batshaw ML, Suss R, et al. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea- cycle enzymopathies[J]. N Engl J Med, 1984, 310 ( 23 ) : 1500- 1505.
  • 4Uchino T, Endo F, Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan [ J ]. J Inherit Metab Dis,1998,21 Suppl 1:151-159.
  • 5Enns GM, Berry SA, Berry GT, et al. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders[J]. N Engl JMed,2007, 356(22) :2282-2292.
  • 6Haberle J, Boddaert N, Burlina A, et al. Alberto Burlina et al. Suggested guidelines for the diagnosis and management of urea cycle disorders [ J ]. Orphanet J Rare Dis, 2012,7 ( 32 ) : 1-30.
  • 7Rtiegger CM, Lindner M, Ballhausen D, et al. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders[J]. J Inherit Metab Dis ,2014, 37( 1 ) :21-30.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部